EP3353212
HÁMÖRKUÐ TVÍSÉRTÆK AND-CD3-MÓTEFNI OG NOTAGILDI ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.9.2016EP published:
3.11.2021EP application number:
16781236.1
EP translation filed:
8.12.2021Grant published:
15.2.2022EPO information:
European Patent Register
Max expiry date:
22.9.2036Expiry date:
22.9.2026Next due date:
30.9.2026
Title in English:
OPTIMIZED ANTI-CD3 BISPECIFIC ANTIBODIES AND USES THEREOFLanguage of the patent:
English
Timeline
Today
23.9.2016EP application
3.11.2021EP Publication
8.12.2021Translation submitted
15.2.2022Registration published
22.9.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Inventor
Name:
SMITH, EricAddress:
Tarrytown, New York 10591-6707, US
Name:
HABER, LauricAddress:
Tarrytown, New York 10591-6707, US
Name:
BABB, RobertAddress:
Tarrytown, New York 10591-6707, US
Name:
CHEN, GangAddress:
Tarrytown, New York 10591-6707, US
Name:
MACDONALD, DouglasAddress:
Tarrytown, New York 10591-6707, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201562222605 PDate:
23.9.2015Country:
US
Classification
Categories:
C07K 16/28, C07K 16/30, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 19.8.2022
Expires: 22.9.2023
Payer: Patice ehf.
Number: 8
Paid: 15.9.2023
Expires: 22.9.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 22.8.2024
Expires: 22.9.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 15.9.2025
Expires: 22.9.2026
Payer: Árnason Faktor ehf.